Bacterial and endotoxin permeability of hemodiaiysis membranes

Bernick, John J.; Port, Friedrich K.; Favero, Martin S.; Brown, Don G.
October 1979
Kidney International;Oct1979, Vol. 16 Issue 4, p491
Academic Journal
Dialysis fluids containing at least 107 bacteria per milliliter and as much as 12,500 ng of endotoxin equivalents per milliliter were dialyzed and ultrafiltered with three types of disposable hemodialyzers. Neither bacteria nor endotoxin, as measured by the Limulus lysate assay, was detected in the sterile compartment despite ultrafiltration. Under these favorable conditions for endotoxin transfer, the maximum transfer rate was calculated to be less than 3.5 ng of endotoxin equivalents per hour. At this rate, it is unlikely that pyrexia during hemodialysis is due to the transfer of endotoxin across an intact dialyzing membrane. Provided that the integrity of the dialyzing membrane is maintained, this investigation indicates that the risk of endotoxemia or bacteremia associated with the use of contaminated dialysis fluids is negligible.


Related Articles

  • Dialysate delivery: Historical, theoretical, and practical aspect. Friedman, Eli A.; Lundin III, Andrew P. // Kidney International Supplement;Sep1980, Issue 10, pS-33 

    Maintenance hemodialysis has progressed from a tentative therapy for a few patients in Seattle to a generally available treatment sustaining 100,000 patients around the world. The technical principles of dialysis are sufficiently understood to permit fabrication of disposable dialyzers in sheet,...

  • Treatment of hirudin overdosage in a dialysis patient with heparin-induced thrombocytopenia with mixed hemodialysis and hemofiltration treatment. Mon, C.; Moreno, G.; Ortiz, M.; Diaz, R.; Herrero, J. C.; Oliet, A.; Rodriguez, I.; Ortega, O.; Gallar, P.; Vigil, A. // Clinical Nephrology;2006, Vol. 66 Issue 4, p302 

    We report a patient who developed type II heparin-induced thrombocytopenia (HIT) and accidentally received a recombinant hirudin (r-hirudin) overdosage. Treatment with hemodialysis (HD) using high-flux polysulfone dialyzer and hemofiltration was performed. Length of treatment was adjusted,...

  • Gentamicin pharmacokinetics during hemodialysis. Christopher, T. G.; Korn, D.; Blair, A. D.; Forrey, A. W.; O'Neill, M. A.; Cutler, R. E. // Kidney International;Jul1974, Vol. 6 Issue 1, p38 

    Previous research has permitted the development of a method for the estimation of gentamicin dosage requirement for varying degrees of renal insufficiency. In the present study we have undertaken precise measurement of the Kiil hemodialyzer clearance of gentamicin and have extended earlier...

  • Photoelectric measurement of blood flow during hemodialysis. Peoples, Ralph W.; Cole, James J.; Vizzo, Joseph E.; Leith, William C.; Blagg, Christopher R. // Kidney International;Jan1973, Vol. 3 Issue 1, p190 

    The article presents information on the use of photoelectric measurements of blood flow rate during hemodialysis for determining hemodialyzer performance. The light-sensitive areas of phototransistors are normally darkened by blood contained in the tubing between light source and transistors....

  • Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro hemodialysis. Tielemans, Christian; Husson, Cécile; Schurmans, Thierry; Gastaldello, Karine; Madhoun, Philippe; Delville, Jean-Pierre; Marchant, Arnaud; Goldman, Michel; Vanherweghem, Jean-Louis // Kidney International;Jan1996, Vol. 49 Issue 1, p236 

    Several studies support the hypothesis that bacterial contamination of the dialysate stimulates the inflammatory response to hemodialysis (HD) and increases the long-term morbidity of HD patients; this phenomenon could also be modulated by the nature of the HD membrane. Therefore, this study was...

  • Recommendations for quantification of dialysis therapy in research protocols. Gotch, Frank A. // Kidney International Supplement;Jan1975, Issue 2, pS-246 

    In this article, the author presents information on some recommendations for quantification of dialysis therapy in research protocols. During intermittent hemodialysis therapy the stable patient will be in solute mass balance over each successive dialysis cycle. The solute removed during...

  • Low molecular weight heparin in hemodialysis and hemofiltration patients. Schrader, Joachim; Valentin, Rainer; Tönnis, Hans-Joachim; Hildebreand, Udo; Stibbe, Werner; Armstrong, Victor W.; Kandt, Michael; Köstering, Heinz; Quellhorst, Eduard // Kidney International;Nov1985, Vol. 28 Issue 5, p823 

    Low molecular weight (LMW)-heparin was used as the sole anticoagulant during hemodialysis and hemofiltration in a pilot study on 32 patients. A LMW-heparin dose corresponding to 50% of the patients usual unfractionated, standard (UF)-heparin dose was found to produce comparable plasma heparin...

  • Closing the loop in hemofiltration. Burton, Benjamin T. // Kidney International Supplement;Sep1980, Issue 10, pS-93 

    Hemofiltration may become a promising method for the maintenance treatment of patients with end-stage renal disease provided further clinical tests demonstrate its clinical efficacy as compared to conventional hemodialysis (and particularly if long-term clinical advantages can be demonstrated),...

  • Discussion on hemofiltration.  // Kidney International Supplement;Sep1980, Issue 10, pS-100 

    Presents a discussion on hemofiltration, held at the Conference on Advances in Dialysis held on April 6, 1979 in Chicago, Illinois. Use of hypernatremic fluid as replacement fluid in the system; Calculation of the surge of free water clearance; Problem of calculating generation rates.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics